3-bromocyclobutan-1-ol

Catalog No.: 
ACIJUG296
CAS No.: 
1552270-60-6
Molecular Formula: 
C4H7BrO
Molecular Weight: 
151.00
3-bromocyclobutan-1-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$248.00In stockIn stock
250mg98%$330.00In stockIn stock
500mg98%$551.00In stockInquiry
1g98%$825.00In stockIn stock

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-bromocyclobutan-1-ol
IUPAC Name3-bromocyclobutan-1-ol
MDL No.MFCD30180931
Molecular FormulaC4H7BrO
Molecular Weight151.00
SMILESOC1CC(Br)C1
InChI KeyHWLHFIFQJICDNX-UHFFFAOYSA-N
SynonymEN300-254257 | cis-3-Bromocyclobutan-1-ol | CS-0197830 | 1909286-42-5 | AT17315 | SCHEMBL24608465 | 2243501-46-2 | (1s,3s)-3-bromocyclobutan-1-ol | 3-bromocyclobutan-1-ol | CMC27060 | MFCD30180931 | EN300-6490216 | AT12399 | AT12400 | PS-18643 | SY209516
CAS No.1552270-60-6
PubChem CID121553408

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACIJUG296 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMAGE045 route compound structure diagram
    ACMAGE04523761-24-2In Stock
  2. Then
  3. ACIJUG296 route product structure diagram
    ACIJUG2961552270-60-6In Stock
Inquiry

2. ACIJUG296 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBQDZ537 route compound structure diagram
    ACBQDZ53763518-47-8In Stock
  4. Then
  5. ACIJUG296 route product structure diagram
    ACIJUG2961552270-60-6In Stock
Inquiry

3. ACIJUG296 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIJUG296 route product structure diagram
    ACIJUG2961552270-60-6In Stock
Inquiry

Comments (0)